The global COVID-19 Vaccine Development Tools market accrued earnings worth approximately 15.5(USD Billion) in 2020 and is predicted to gain revenue of about 22.7(USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
The global COVID-19 Vaccine Development Tools market accrued earnings worth approximately 15.5(USD Billion) in 2020 and is predicted to gain revenue of about 22.7(USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028. The report offers assessment and analysis of the COVID-19 Vaccine Development Tools market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Development of vaccines for COVID-19 is a key for global economy to return to normalcy and hence various efforts & investments have been made by many countries for developing vaccines for offering protection to individuals against SARS-CoV-2 virus. According to NCBI, till March 2021, nearly 13 vaccines were approved for use and nearly more than 90 vaccines were undergoing phases of clinical trials. In addition to this, artificial intelligence and machine learning have proved to be effective tools in developing of COVID-19 vaccines. According to WHO, major components in vaccine development include antigens, residuals, preservatives, diluent, stabilizers, and surfactants and are manufactured by reputed pharma firms Pfizer, BioNTech, and Merck.
Furthermore, vaccine development can take many years of research before it can be approved for medical use by statutory (medical) authorities. Vaccine Inoculation for larger population becomes possible only after approval of vaccines. After development of new vaccine, it is tested in three phases. Phase I or preclinical phase includes testing of vaccines on animals and then on limited number of individuals to record or report stimulation of immune system due to vaccine injection. The Phase II testing includes vaccine inoculation in many persons involving old persons & children, thereby proving safety of vaccine inoculation in persons belonging to different age-groups. Final phase includes phase III clinical trials of vaccine performed on a large percentage of population. Apparently, these phase III clinical studies determine the effectiveness of vaccines against coronavirus without any side effects, thereby helping researchers in determining efficiency of vaccines. Based on success of Phase III trials, healthcare authorities decide on providing restricted approval for vaccines. After that, state officials review overall outcomes of clinical trials and based on that decide on fully approving production & use of vaccines.
Increase in number of vaccine producers in both emerging economies and developed countries will boost growth of COVID-19 vaccine development tools market in upcoming years. Large-scale use of AI tools in development of COVID-19 vaccine and surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance expansion of COVID-19 vaccine development tools industry in foreseeable future. Citing an instance, AstraZeneca entering into partnership with Serum Institute in India for developing Covishield Vaccine. Another instance is of Sanofi aiding production of COVID-19 vaccine by combined Pfizer-BioNtech firms through offering of services of bottle filling & packing for vaccines to latter. Favorable government legislations & incentives will prop up expansion of industry in years ahead.
Furthermore, need for avoiding COVID-19 vaccine manufacturing delays will promulgate growth of Covid-19 vaccine development tool market over forthcoming years. Enormous funding of research & development activities by private firms as well as government organizations for developing effective vaccines against COVID-19 for combating spread of COVID-19 pandemic along with reducing its intensity & effect through enhancing if human body immunity will steer market trends.
The expansion of COVID-19 vaccine development tools market in Asia Pacific during assessment period can be credited to prominent surge in vaccine development for COVID-19 in countries such as India, Israel, and China. Furthermore, determining of new COVID genome in initial stage through use of modern sequencing tools by researchers of sub-continent will expedite business landscape in Asia Pacific over ensuing years. Additionally, large-scale utilization of genome sequencing tools, viral structure examination tools, and immune response profiling systems for developing new vaccines against COVID-19 will steer regional industry trends.
Key players profiled in study include Thermo Fisher Scientific, Inc., Pfizer Inc., Celerion, Sartorius AG, Cole-Parmer Instrument Company, LLC, STEMCELL Technologies Inc., Illumina, Inc., AB Sciex Private Limited, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck KgaA, Shimadzu Corporation, PerkinElmer Inc., Eurofins Scientific, and Aurora Biomed Inc.
List of Figures
1. Market research Type
2. Market research methodology
3. Global COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global COVID-19 Vaccine Development Tools Marketattractiveness, By Technology
6. Global COVID-19 Vaccine Development Tools Marketattractiveness, By End-Use
7. Global COVID-19 Vaccine Development Tools Marketshare by Technology ,2020 and 2028 (USD Billion)
8. Global COVID-19 Vaccine Development Tools Marketby Lab Technologies, 2018–2028(USD Billion)
9. Global COVID-19 Vaccine Development Tools Marketby PCR & qPCR, 2018–2028(USD Billion)
10. Global COVID-19 Vaccine Development Tools Marketby Flow Cytometry, 2018–2028(USD Billion)
11. Global COVID-19 Vaccine Development Tools Marketby Spectrometry, 2018–2028(USD Billion)
12. Global COVID-19 Vaccine Development Tools Marketby Electron Microscopy, 2018–2028(USD Billion)
13. Global COVID-19 Vaccine Development Tools Marketby Next Generation Sequencing, 2018–2028(USD Billion)
14. Global COVID-19 Vaccine Development Tools Marketshare by End-Use ,2020 and 2028 (USD Billion)
15. Global COVID-19 Vaccine Development Tools Marketby CROs , 2018–2028(USD Billion)
16. Global COVID-19 Vaccine Development Tools Marketby Pharma & BioPharma Firms, 2018–2028(USD Billion)
17. Global COVID-19 Vaccine Development Tools Marketshare, by Region, 2020 and 2028
18. North America COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
19. Europe COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
20. Asia Pacific COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
21. Latin America COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
22. The Middle East and Africa COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
List of Tables
1. Global COVID-19 Vaccine Development Tools Market: snapshot
2. Drivers of the COVID-19 Vaccine Development Tools Market: impact analysis
3. North America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
4. North America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
5. The U.S. COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
6. The U.S. COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
7. Rest of North America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
8. Rest of North America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
9. Europe COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
10. Europe COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
11. UK COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
12. UK COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
13. France COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
14. France COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
15. Germany COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
16. Germany COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
17. Rest of Europe COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
18. Rest of Europe COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
19. Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
20. Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
21. China COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
22. China COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
23. Japan COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
24. Japan COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
25. India COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
26. India COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
27. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
28. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
29. Latin America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
30. Latin America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
31. Brazil COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
32. Brazil COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
33. Rest of Latin America COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
34. Rest of Latin America COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
35. The Middle East and Africa COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
36. The Middle East and Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
37. Saudi Arabia COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
38. Saudi Arabia COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
39. South Africa COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
40. South Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa COVID-19 Vaccine Development Tools Market revenue, By Technology ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use ,2018–2028(USD Billion)
Increase in number of vaccine producers in both emerging economies and developed countries will boost growth of COVID-19 vaccine development tools market in upcoming years. Large-scale use of AI tools in development of COVID-19 vaccine and surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance expansion of COVID-19 vaccine development tools industry in foreseeable future. Citing an instance, AstraZeneca entering into partnership with Serum Institute in India for developing Covishield Vaccine. Another instance is of Sanofi aiding production of COVID-19 vaccine by combined Pfizer-BioNtech firms through offering of services of bottle filling & packing for vaccines to latter. Favorable government legislations & incentives will prop up expansion of industry in years ahead. Furthermore, need for avoiding COVID-19 vaccine manufacturing delays will promulgate growth of Covid-19 vaccine development tool market over forthcoming years.
According to Zion market research report, the global COVID-19 Vaccine Development Tools market accrued earnings worth approximately 15.5(USD Billion) in 2020 and is predicted to gain revenue of about 22.7(USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
Asia Pacific will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is owing to prominent surge in vaccine development for COVID-19 in countries such as India, Israel, and China. Furthermore, determining of new COVID genome in initial stage through use of modern sequencing tools by researchers of sub-continent will expedite business landscape in Asia Pacific over ensuing years. Additionally, large-scale utilization of genome sequencing tools, viral structure examination tools, and immune response profiling systems for developing new vaccines against COVID-19 will steer regional industry trends.
The key market participants include Thermo Fisher Scientific, Inc., Pfizer Inc., Celerion, Sartorius AG, Cole-Parmer Instrument Company, LLC, STEMCELL Technologies Inc., Illumina, Inc., AB Sciex Private Limited, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck KgaA, Shimadzu Corporation, PerkinElmer Inc., Eurofins Scientific, and Aurora Biomed Inc.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed